Page last updated: 2024-08-25

sofosbuvir and Respiratory Syndrome, Acute, Severe

sofosbuvir has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Becerra, A; Campillo-Balderas, JA; Jácome, R; Lazcano, A; Ponce de León, S1

Other Studies

1 other study(ies) available for sofosbuvir and Respiratory Syndrome, Acute, Severe

ArticleYear
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic.
    Scientific reports, 2020, 06-09, Volume: 10, Issue:1

    Topics: Antiviral Agents; Base Sequence; Betacoronavirus; Catalytic Domain; Computer Simulation; Coronavirus Infections; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Protein Binding; Protein Structure, Tertiary; RNA-Dependent RNA Polymerase; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Sofosbuvir; Viral Nonstructural Proteins

2020